Overview
Marvin Mergen practices in Homburg, Germany. Mr. Mergen is rated as an Advanced expert by MediFind in the treatment of Wilms Tumor. His top areas of expertise are Wilms Tumor, Congenital Mesoblastic Nephroma, Renal Cell Carcinoma (RCC), and Rhabdoid Tumor.
His clinical research consists of co-authoring 12 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 6 articles in the study of Wilms Tumor.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Wilms TumorMr. Mergen isAdvanced. Learn about Wilms Tumor.
- Experienced
- Congenital Mesoblastic NephromaMr. Mergen isExperienced. Learn about Congenital Mesoblastic Nephroma.
- Renal Cell Carcinoma (RCC)Mr. Mergen isExperienced. Learn about Renal Cell Carcinoma (RCC).
- Rhabdoid TumorMr. Mergen isExperienced. Learn about Rhabdoid Tumor.